Patents matching “air”

CA 3203431

PROCEDES D'AMELIORATION DE RENDEMENT MUSCULAIRE OU DE REDUCTION DE FATIGUE CHRONIQUE PAR ADMINISTRATION D'EXOSOMES DERIVES DU LAIT BOVIN

ABBOTT LAB [US] · Granted Jul 7, 2022 · Expires Jul 2, 2042

US 11377491

Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer

The Board of Regents of the University of Texas System · Granted Jul 5, 2022 · Expires Jun 30, 2042

US 11377659

Short hairpin RNA (shRNA734) and use of same to positively select and eliminate genetically modified cells

THE REGENTS OF THE UNIVERSITY OE CALIFORNIA · Granted Jul 5, 2022 · Expires Jun 30, 2042

US 11371024

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 28, 2022 · Expires Jun 23, 2042

US 11357832

Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase

Takeda Pharmaceutical Company Limited · Granted Jun 14, 2022 · Expires Jun 9, 2042

US 11352389

Treatment of haematological malignancies

Academisch Ziekenhuis Leiden h.o.d.n. Leids Universitair Medisch Centrum · Granted Jun 7, 2022 · Expires Jun 2, 2042

US 11354990

Treatment of kidney diseases associated with elevated AVP

United States Government as represented by the Department of Veterans Affairs · Granted Jun 7, 2022 · Expires Jun 2, 2042

US 11345894

Cellular seeding and co-culture of a three dimensional fibroblast construct

United States Government as represented by the Department of Veterans Affairs · Granted May 31, 2022 · Expires May 26, 2042

CA 3198544

PROCEDES D'AUGMENTATION DE LA TAILLE ET DE PROMOTION DE LA CROISSANCE OSSEUSE LINEAIRE

ABBOTT LAB [US] · Granted May 27, 2022 · Expires May 22, 2042

US 11338037

Ultrastable antibody ionic liquids

United States of America as represented by the Secretary of the Air Force · Granted May 24, 2022 · Expires May 19, 2042

US 11318190

Methods and compositions for treating liver disease

United States Government as represented by the Department of Veterans Affairs · Granted May 3, 2022 · Expires Apr 28, 2042

US 11312714

Compositions and methods for modulating hair growth

The Regents of the University of California · Granted Apr 26, 2022 · Expires Apr 21, 2042

US 11306122

Compositions and methods of inhibiting the binding of plasma IgG autoantibodies to serotonin 2A receptor

United States Government as represented by the Department of Veterans Affairs · Granted Apr 19, 2022 · Expires Apr 14, 2042

US 11298561

Method of treating multi-drug resistance biofilm using targeted laser and antibiotics

United States of America as represented by the Secretary of the Air Force · Granted Apr 12, 2022 · Expires Apr 7, 2042

US 11291712

Bacterial protein compositions and uses thereof

United States Government as represented by the Department of Veterans Affairs · Granted Apr 5, 2022 · Expires Mar 31, 2042

US 11287427

Application of anti-CD39L3 antibodies for use in disease diagnostics and imaging

THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Mar 29, 2022 · Expires Mar 24, 2042

US 11285100

Freeze-dried polymer compositions for mixing with platelet rich plasma to form implants for tissue repair and/or compositions for therapeutic intra-articular injections

ORTHO REGENERATIVE TECHNOLOGIES INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

US 11285154

Methods and compositions for treating cancer

United States Government as represented by the Department of Veterans Affairs · Granted Mar 29, 2022 · Expires Mar 24, 2042

US 11286352

Process for preparation of beads for imaging

Stichting Radboud universitair medisch centrum · Granted Mar 29, 2022 · Expires Mar 24, 2042

US 11279933

Antisense oligonucleotides for the treatment of leber congenital amaurosis

Stichting Radboud universitair medisch centrum · Granted Mar 22, 2022 · Expires Mar 17, 2042

US 11278521

GAS5 binding compounds, formulations, and uses thereof

THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS OFFICE OF GENERAL COUNSEL—PSG IV (024) · Granted Mar 22, 2022 · Expires Mar 17, 2042

US 11278573

Methods and compositions to facilitate repair of avascular tissue

Regenexx, LLC · Granted Mar 22, 2022 · Expires Mar 17, 2042

US 11274305

Compositions and methods for in vivo excision of HIV-1 proviral DNA

United States Government as represented by the Department of Veterans Affairs · Granted Mar 15, 2022 · Expires Mar 10, 2042

US 11274303

Olmalinc as a diagnostic and therapeutic target for NAFLD, NASH, metabolic syndrome, and hepatic fibrosis

The United States Government represented by the Department of Veterans Affairs · Granted Mar 15, 2022 · Expires Mar 10, 2042